Home/Filings/4/0001011034-09-000048
4//SEC Filing

KEMPF DAVID A 4

Accession 0001011034-09-000048

CIK 0001443062other

Filed

May 3, 8:00 PM ET

Accepted

May 4, 4:13 PM ET

Size

11.0 KB

Accession

0001011034-09-000048

Insider Transaction Report

Form 4
Period: 2009-03-10
KEMPF DAVID A
DirectorCOO/CFO
Transactions
  • Purchase

    Series A Convertible Preferred Stock

    2009-04-15$1.00/sh+5,000$5,0005,000 total
  • Purchase

    Common Stock

    2009-03-10$0.49/sh+200$983,000 total(indirect: By IRA)
Holdings
  • Options

    Exercise: $1.00From: 2011-02-11Exp: 2019-02-11common stock (100,000 underlying)
    200,000
  • Common Stock

    (indirect: By IRA)
    2,800
  • Options

    Exercise: $1.00From: 2010-02-11Exp: 2019-02-11common stock (100,000 underlying)
    100,000
  • Options

    Exercise: $1.00From: 2012-02-11Exp: 2019-02-11common stock (100,000 underlying)
    300,000

Issuer

BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS INC

CIK 0001443062

Entity typeother

Related Parties

1
  • filerCIK 0001458510

Filing Metadata

Form type
4
Filed
May 3, 8:00 PM ET
Accepted
May 4, 4:13 PM ET
Size
11.0 KB